An Aspirin a
Day May Still Lower Cancer Risk, but Not as Much as Previously Thought
A new study
offers fresh evidence that popping a daily aspirin is associated with a lower
risk of dying from cancer, but the size of the potential protective effect may
be smaller than previous research has suggested
By Alexandra Sifferlin. In TIME
Radiation
after lumpectomy helps prevent need for mastectomy in early stage breast cancer
Contrary to
clinical recommendations, older women with early stage breast cancer may want
to undergo radiation after lumpectomy to help ensure that they will not need a
mastectomy in the future. That is the conclusion of a new study published early
online in CANCER, a peer-reviewed journal of the American Cancer Society. The
findings indicate that current thinking on the risks and benefits of radiation
for early stage breast cancer in older women may be inaccurate.
In Science Codex
Early Breast
Cancer in Older Women: Mastectomies Avoidable for Some
A study
published in Cancer, the journal of the American Cancer Society, provides
evidence that older women with early-stage breast cancer who undergo radiation
therapy following a lumpectomy are less likely to require a subsequent
mastectomy. This is contrary to current recommendations that suggest radiation
therapy does not play a role in determining whether an older woman will need a
mastectomy following a lumpectomy for her early-stage breast cancer. The
authors suggest the current recommendations are based on inaccurate thinking of
the risks and benefits of radiation therapy.
By Anna Azvolinsky. In Cancer
Network
Komen's
Leadership Changes Are Met With Skepticism
Leadership
changes at the Susan G. Komen Foundation for the Cure six months after an
online uproar over a decision to cut funds for breast cancer screenings at
Planned Parenthood was greeted with skepticism on Thursday among breast cancer
advocates and longtime former supporters.
By Jennifer Preston. In New York Times (blog)
Screening
Debate Typifies Prostate Cancer Uncertainties
Experts
differ, leaving men with no easy answers.
By Serena Gordon. In U.S.
La surcharge pondérale favorise (aussi) les seconds cancers
Combattre le surpoids permet de réduire le risque de
développer une deuxième tumeur, voire un premier cancer du sein.
Par Anne
Jeanblanc. Dans Le Point
Cancer du sein: médicament de Roche homologué en Suisse
L'homologation se fonde sur les résultats d'une étude qui a
montré que les patientes ayant reçu le traitement combiné par Perjeta ont vécu
en moyenne six mois de plus sans aggravation de leur tumeur cancéreuse.
Dans 24heures.ch
Un cachet d'aspirine par jour réduit
les risques de mourir d'un cancer
Selon les chercheurs, le risque serait diminué de 16%.
Dans Atlantico.fr
Aucun commentaire:
Enregistrer un commentaire